In DSAD, the triplication of APP can be seen as conferring genetic risk for AD by driving Aβ accumulation, with other genes on chr21 compounding effects through altering energy metabolism, inflammation, oxidative stress, and autonomic functioning.4, 13. Here, APP is linked to Alzheimer disease.